Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA – Get Free Report) was the recipient of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 283,900 shares, a drop of 51.6% from the May 31st total of 586,700 shares. Based on an average trading volume of 3,880,000 shares, the short-interest ratio is currently 0.1 days.
Sonoma Pharmaceuticals Stock Performance
Shares of Sonoma Pharmaceuticals stock remained flat at $0.21 during trading hours on Friday. The stock had a trading volume of 5,923,486 shares, compared to its average volume of 3,010,728. Sonoma Pharmaceuticals has a 52-week low of $0.12 and a 52-week high of $1.19. The company has a market cap of $4.03 million, a price-to-earnings ratio of -0.30 and a beta of 1.37. The business has a 50 day moving average price of $0.18 and a two-hundred day moving average price of $0.17.
Sonoma Pharmaceuticals Company Profile
Recommended Stories
- Five stocks we like better than Sonoma Pharmaceuticals
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- The Role Economic Reports Play in a Successful Investment Strategy
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- Insider Trading – What You Need to Know
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Sonoma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonoma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.